Cybin (HELP) Shares Outstanding (2020 - 2026)

Cybin (HELP) posted quarterly Shares Outstanding (Entity) of $34.8 million for Q1 2026, up 1547.62% year-on-year from $2.1 million in Q1 2025, and up 859.29% on a QoQ basis from $3.6 million in Q3 2025.

Cybin (HELP) Shares Outstanding (2020 - 2026) Analysis & Trends

Cybin (HELP) has reported Shares Outstanding (Entity) for 7 consecutive years, with $34.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 1547.62% year-over-year to $34.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.8 million (up 1547.62% YoY) and the FY2026 annual result came in at $34.8 million, up 1496.22% from the prior year.
  • Shares Outstanding (Entity) improved to $34.8 million in Q1 2026 per HELP's latest filing, from $3.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for HELP reached as high as $34.8 million in Q1 2026 and fell as low as $546976.8 in Q3 2022.
  • A 5-year average of $3.5 million and a median of $980221.0 in 2022 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) grew 2.08% — and 2026, when it soared 1547.62%.
  • Year by year, Shares Outstanding (Entity) stood at $548940.2 in 2022, then soared by 76.14% to $966879.4 in 2023, then surged by 121.95% to $2.1 million in 2024, then surged by 69.06% to $3.6 million in 2025, then jumped by 859.29% to $34.8 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $34.8 million, $3.6 million, and $2.4 million for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Cybin 28.04 Mn 28.04 Mn - 34.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 34.80 Mn
Dec 31, 2025 42.52 Mn
Sep 30, 2025 24.21 Mn
Jun 30, 2025 22.40 Mn
Mar 31, 2025 20.22 Mn
Dec 31, 2024 20.00 Mn
Sep 30, 2024 20.00 Mn
Jun 30, 2024 20.00 Mn
Mar 31, 2024 8.30 Mn
Dec 31, 2023 8.78 Mn
Sep 30, 2023 6.17 Mn
Jun 30, 2023 5.43 Mn
Feb 28, 2023 8.46 Mn
Dec 31, 2022 4.97 Mn
Sep 30, 2022 4.76 Mn
May 31, 2022 8.42 Mn
Mar 31, 2022 4.40 Mn
Feb 28, 2022 4.52 Mn
Dec 31, 2021 4.52 Mn
Sep 30, 2021 4.36 Mn